01150nas a2200289   4500000000100000008004100001260001700042653001200059653002300071653001600094653003200110653001500142653001100157653002300168653001800191653001200209653000900221653002400230653002500254100001200279245006200291300001100353490000700364050003200371520044300403022001400846       1984                            d  c1984 Oct-Dec10aAnimals10aBacterial Vaccines10aBCG Vaccine10aEvaluation Studies as Topic10aHaplorhini10aHumans10aImmunity, Cellular10aImmunotherapy10aleprosy10aMice10aMycobacterium avium10aMycobacterium leprae1 aDeo M G00aAnti-leprosy vaccines--field trials and future prospects.  a764-750 v56  aInfolep Library - available3 a<p>Development of a vaccine for prevention of leprosy is today one of the major challenges for bio-medical sciences. Two vaccines containing (i) M. leprae + BCG and (ii) ICRC, a cultivable mycobacterium, have reached advanced stage with reference to human trials. This article describes comparative features of two vaccines and mechanism of their action. Future possibilities with reference to anti-leprosy vaccine are also discussed.</p>  a0254-9395